Related references
Note: Only part of the references are listed.Effectiveness and Safety of Subcutaneous Rituximab for Patients With Gastric MALT Lymphoma: A Case-Control Comparison With Intravenous Rituximab
Hugo Rotkopf et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2021)
Radiation therapy for salivary gland MALT lymphoma: ultra-low dose treatment achieves encouraging early outcomes and spares salivary function*
Jillian R. Gunther et al.
LEUKEMIA & LYMPHOMA (2020)
Outcomes After Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma
Chelsea C. Pinnix et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Sequential H. pylori eradication and radiation therapy with reduced dose compared to standard dose for gastric MALT lymphoma stages IE & II1E: a prospective randomized trial
Renate Schmelz et al.
JOURNAL OF GASTROENTEROLOGY (2019)
Randomized Trial of Systemic Therapy After Involved-Field Radiotherapy in Patients With Early-Stage Follicular Lymphoma: TROG 99.03
Michael MacManus et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Long-term outcome of 487 patients with early-stage extra-nodal marginal zone lymphoma
S. Teckie et al.
ANNALS OF ONCOLOGY (2017)
Clinicopathologic Characteristics and Treatment of Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)
Markus Raderer et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Steven H. Swerdlow et al.
BLOOD (2016)
Review article: Mucosa-associated lymphoid tissue (MALT)-type lymphoma of ocular adnexa. Biology and treatment
Ombretta Annibali et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Low level autoantibodies can be frequently detected in the general Australian population
Pooja Deshpande et al.
PATHOLOGY (2016)
Exclusive moderate-dose radiotherapy in gastric marginal zone B-cell MALT lymphoma: Results of a prospective study with a long term follow-up
Agnes Ruskone-Fourmestraux et al.
RADIOTHERAPY AND ONCOLOGY (2015)
4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non- inferiority trial
Peter J. Hoskin et al.
LANCET ONCOLOGY (2014)
Long-term follow-up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment
Julien Lenglet et al.
LEUKEMIA & LYMPHOMA (2014)
Recognizing nodal marginal zone lymphoma: recent advances and pitfalls. A systematic review
Michiel van den Brand et al.
HAEMATOLOGICA (2013)
A Retrospective Study of 5-year Outcomes of Radiotherapy for Gastric Mucosa-associated Lymphoid Tissue Lymphoma Refractory to Helicobacter pylori Eradication Therapy
Seiichiro Abe et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2013)
Chlamydia psittaci Infection in Nongastrointestinal Extranodal MALT Lymphomas and Their Precursor Lesions
Ariane Aigelsreiter et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)
t(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement
Sung-Hsin Kuo et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Genomic profiles of MALT lymphomas: variability across anatomical sites
Ivo Kwee et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
OCULAR RISKS FROM ORBITAL AND PERIORBITAL RADIATION THERAPY: A CRITICAL REVIEW
V. Swetha E. Jeganathan et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Sjogren's Syndrome and MALT Lymphoma
Paul Ornetti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: A randomised phase III trial
Lisa Lowry et al.
RADIOTHERAPY AND ONCOLOGY (2011)
Long-Term Outcome in Localized Extranodal Mucosa-Associated Lymphoid Tissue Lymphomas Treated With Radiotherapy
Jayant S. Goda et al.
CANCER (2010)
Chronic autoimmune thyroiditis (Hashimoto's thyroiditis) in patients with MALT lymphoma
M. Troch et al.
ANNALS OF ONCOLOGY (2008)
Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy
A. J. M. Ferreri et al.
ANNALS OF ONCOLOGY (2008)
Borrelia infection and risk of non-Hodgkin lymphoma
Claudia Schollkopf et al.
BLOOD (2008)
The seroepidemiology of Helicobacter pylori infection in Australia
T. Moujaber et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2008)
Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions
E. Chanudet et al.
JOURNAL OF PATHOLOGY (2006)
Antibiotic treatment is not effective in patients infected with Helicobacter pylori suffering from extragastric MALT lymphoma
B Grünberger et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Stage I and II malt lymphoma: Results of treatment with radiotherapy
RW Tsang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)